| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/03008207.2015.1045065 |
| P698 | PubMed publication ID | 25943461 |
| P50 | author | Giovanna Chiorino | Q38304620 |
| Ezia Bello | Q43223594 | ||
| Giulia Taraboletti | Q51136302 | ||
| Roberta Frapolli | Q73145172 | ||
| P2093 | author name string | Paola Ostano | |
| Patrizia Borsotti | |||
| Francesca Bizzaro | |||
| Federica Guffanti | |||
| Denise Pinessi | |||
| Maria Rosa Bani | |||
| Andrea Resovi | |||
| P2860 | cites work | Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes | Q38303931 |
| A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype | Q40310331 | ||
| Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2. | Q42835129 | ||
| Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia | Q46114146 | ||
| Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study | Q53424963 | ||
| Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features. | Q54335819 | ||
| The genesis and evolution of high-grade serous ovarian cancer | Q55053523 | ||
| Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations | Q57819003 | ||
| Bioconductor: open software development for computational biology and bioinformatics | Q21194861 | ||
| Revisiting the complexity of the ovarian cancer microenvironment--clinical implications for treatment strategies | Q26991951 | ||
| The changing view of high-grade serous ovarian cancer | Q27025411 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| A novel cancer therapeutic using thrombospondin 1 in dendritic cells | Q28395685 | ||
| TM4 microarray software suite | Q29618829 | ||
| Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer | Q30497303 | ||
| Analysis of microarray data using Z score transformation | Q30787499 | ||
| Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. | Q30914170 | ||
| Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components | Q33245035 | ||
| Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis | Q33896683 | ||
| Ovarian cancer development and metastasis | Q34086819 | ||
| p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers | Q34227513 | ||
| Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer. | Q35039333 | ||
| In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects | Q35079190 | ||
| Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm | Q35140600 | ||
| The thrombospondins. | Q35230013 | ||
| Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2 | Q35902676 | ||
| Rethinking ovarian cancer: recommendations for improving outcomes | Q36050883 | ||
| Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy | Q36689936 | ||
| Structures of thrombospondins | Q36962766 | ||
| Thrombospondins in cancer | Q37056249 | ||
| Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis | Q37064800 | ||
| The effect of thrombospondin-1 on breast cancer metastasis | Q37074568 | ||
| Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study | Q37522638 | ||
| Current understanding of the thrombospondin-1 interactome. | Q38183216 | ||
| Invoking the power of thrombospondins: regulation of thrombospondins expression | Q38192305 | ||
| P433 | issue | 5 | |
| P921 | main subject | xenograft | Q64148587 |
| ovarian carcinoma | Q18556145 | ||
| P304 | page(s) | 355-363 | |
| P577 | publication date | 2015-06-15 | |
| P1433 | published in | Connective Tissue Research | Q15755653 |
| P1476 | title | Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts | |
| P478 | volume | 56 |
| Q41660637 | MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review |
| Q36221374 | Original insights on thrombospondin-1-related antireceptor strategies in cancer |
| Q38822157 | Puzzling and ambivalent roles of malarial infections in cancer development and progression |
| Q47717341 | Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer. |
Search more.